SCHEMBL4282622

SCHEMBL4282622

CCc1ccc(C(OC(C)=O)c2cccnc2OCc2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.47
POLB P06746 2/20 0.41
CNR2 P34972 5/20 0.40
CNR1 P21554 3/20 0.40
MAPK1 P28482 1/20 0.40
TSHR P16473 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
RORC P51449 1/20 0.38
FAAH O00519 3/20 0.37
RXRA P19793 1/20 0.37
RXRB P28702 1/20 0.37
FFAR1 O14842 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4285582 0.88 CNR2 (0.44) L3MBTL1CNR2CNR1TSHRALDH1A1
SCHEMBL4285312 0.85 CNR2 (0.37) L3MBTL1CNR2CNR1MAPK1TSHR
SCHEMBL154396 0.81 L3MBTL1 (0.47) L3MBTL1POLBCNR2CNR1MAPK1
SCHEMBL5395059 0.75 ALDH1A1 (0.41) L3MBTL1CNR2MAPK1TSHRALDH1A1
SCHEMBL4285318 0.74 RXRA (0.38) L3MBTL1POLBALDH1A1MAPTSMN1; SMN2
SCHEMBL27767676 0.73 L3MBTL1 (0.47) L3MBTL1POLBCNR2CNR1MAPK1
SCHEMBL4289336 0.73 CNR2 (0.42) CNR2ALDH1A1HTTFFAR1
SCHEMBL154300 0.72 L3MBTL1 (0.60) L3MBTL1POLBCNR2CNR1MAPK1
SCHEMBL10627201 0.72 FAAH (0.55) CNR2CNR1FAAH
SCHEMBL25466151 0.69 ALDH1A1 (0.53) MAPK1TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 L3MBTL1 2087/4885POLB 4872/4885CNR2 991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.